Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy
Roswell Park Cancer Institute
Roswell Park Cancer Institute
The Methodist Hospital Research Institute
IO Biotech
H. Lee Moffitt Cancer Center and Research Institute
Osijek University Hospital
Merck Sharp & Dohme LLC
Rowan University
UNC Lineberger Comprehensive Cancer Center
Medical College of Wisconsin
Merck Sharp & Dohme LLC
University of Kentucky
National Cancer Institute (NCI)
University of Michigan Rogel Cancer Center
Wake Forest University Health Sciences
H. Lee Moffitt Cancer Center and Research Institute
Milton S. Hershey Medical Center
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
University of California, San Diego
AstraZeneca
Mayo Clinic
National Cancer Institute (NCI)
Yale University
Merck Sharp & Dohme LLC
University of Michigan Rogel Cancer Center
Washington University School of Medicine
Radiation Therapy Oncology Group
Boehringer Ingelheim
University of California, San Francisco
University of Pittsburgh
Varian, a Siemens Healthineers Company
Memorial Sloan Kettering Cancer Center
I-Mab Biopharma US Limited
University of Texas Southwestern Medical Center
University of California, San Francisco
Merck Sharp & Dohme LLC
Incyte Corporation
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Washington University School of Medicine
University of Connecticut
Medical University of South Carolina
University of Florida
Dana-Farber Cancer Institute
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
University of Southern California
Thomas Jefferson University
NRG Oncology
University of Arkansas